Dismantling papillary renal cell carcinoma classification: The heterogeneity of genetic profiles suggests several independent diseases-Reference-Cited by-同舟云学术

Dismantling papillary renal cell carcinoma classification: The heterogeneity of genetic profiles suggests several independent diseases

Published:2015-03-28 Issue:6 Volume:54 Page:369-382
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosomes Cancer

Author:

Marsaud Alexandre¹²,Dadone Bérengère¹³,Ambrosetti Damien¹³,Baudoin Christian¹,Chamorey Emmanuel⁴,Rouleau Etienne⁵,Lefol Cédrick⁵,Roussel Jean‐François⁶,Fabas Thibault⁷,Cristofari Gaël¹,Carpentier Xavier²,Michiels Jean‐François³,Amiel Jean²,Pedeutour Florence¹⁷

Affiliation:

1. Institute for Research on Cancer and Aging of Nice (IRCAN), CNRS UMR 7284/INSERM U1081, University of Nice‐Sophia AntipolisNice France

2. Department of UrologyNice University HospitalNice France

3. Central Laboratory of PathologyNice University HospitalNice France

4. Department of Epidemiology and BiostatisticsAntoine‐Lacassagne CenterNice France

5. Department of GeneticsPharmacogenomic Unit, Institut CurieParis France

6. Department of PathologyPrincess Grace Hospital Monaco

7. Laboratory of Solid Tumors GeneticsNice University HospitalNice France

Funder

Internal Research Program of Nice University Hospital, French National Cancer Institute

Institut National de la Santé et de la Recherche Médicale

Agence Régionale de Santé (ARS) of Provence Alpes Côte d'Azur

Publisher

Wiley

Subject

Cancer Research,Genetics

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/gcc.22248

Reference47 articles.

1. MET Is a Potential Target across All Papillary Renal Cell Carcinomas: Result from a Large Molecular Study of pRCC with CGH Array and Matching Gene Expression Array

2. Cytogenetic features, clinical significance and prognostic impact of type 1 and type 2 papillary renal cell carcinoma

3. WHO Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs 2004 IARC Lyon P Argani M Ladanyi JN Eble G Sauter JI Epstein IA Sesterhenn Renal carcinomas associated with Xp11.2 translocations / TFE3 gene fusions 37 38

4. Trisomy 7 and 17 mark papillary renal cell tumours irrespectively of variation of the phenotype

5. Targeted therapies and the treatment of non-clear cell renal cell carcinoma

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contemporary review of papillary renal cell carcinoma—current state and future directions;Virchows Archiv;2024-07-12

2. Discovery and Validation of Survival-Specific Genes in Papillary Renal Cell Carcinoma Using a Customized Next-Generation Sequencing Gene Panel;Cancers;2024-05-25

3. The prognostic role of histomorphological subtyping in nonmetastatic papillary renal cell carcinoma after curative surgery: is subtype really irrelevant? A propensity score matching analysis of a multi-institutional real life data;Urologic Oncology: Seminars and Original Investigations;2024-05

4. Papillary Renal Cell Carcinoma: Evolving Classification by Combined Morphologic and Molecular Means;Advances in Anatomic Pathology;2024-02-08

5. Mesenchymal–Epithelial Transition Kinase Inhibitor Therapy in Patients with Advanced Papillary Renal-Cell Carcinoma: A Systematic Review and Meta-Analysis;International Journal of Molecular Sciences;2023-12-18